Clinical trial Recruiting at 1 site Observational Ages 18 and up

Using AI to predict outcomes of acute pulmonary embolism

Official title: Prediction of Adverse Outcome of Acute Pulmonary Embolism by Artificial Intelligence System Based on CT Pulmonary Angiography

Run by Shengjing Hospital · NCT05482269 · Data updated 2026-11-12

This study is trying to see if a new AI tool can help predict complications in patients with acute pulmonary embolism based on their CT scans and other health information.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment2000 (estimated)
SponsorShengjing Hospital
Academic / other
Locations1 site (Shenyang, Liaoning)
StatusRecruiting
StartedJanuary 1, 2011
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedMarch 11, 2026
Trial IDNCT05482269 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 years and older diagnosed with pulmonary embolism confirmed by CT pulmonary angiography.

Probably not a fit

Patients who are pregnant, have received reperfusion treatment before admission, or have incomplete data regarding key clinical parameters will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to develop a predictive tool using artificial intelligence to assess adverse outcomes in patients diagnosed with acute pulmonary embolism based on CT pulmonary angiography. It collects clinical, laboratory, and imaging data from patients upon admission and follows them for 30 days to predict potential complications. Patients are divided into derivation and validation cohorts to create and test a multivariable logistic regression model, comparing its effectiveness to existing risk stratification systems.

Why it matters

Potential benefit: If successful, this tool could significantly improve the prediction of adverse outcomes in patients with acute pulmonary embolism, leading to better clinical management.

How similar studies have gone: While the use of AI in predicting clinical outcomes is an emerging field, similar studies have shown promise in other areas of medicine, indicating potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* age of ≥ 18 years and a pulmonary embolism diagnosis based on CT pulmonary angiography

Exclusion Criteria:

* pregnancy
* reception of reperfusion treatment before admission
* missing data regarding CT parameters, echocardiography, cardiac troponin I (c-Tn I), and N-terminal-pro brain natriuretic peptide (NT-pro BNP) levels.

Where it's running

  • Shengjing Hospital
    Shenyang, Liaoning, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.